The invention relates to compositions and formulations comprising isolated acidic fraction of mastic gum and uses thereof for treating impaired neurological functions as well as wound and tissue repair.

The present invention relates to a composition for improving cognitive ability, and preventing or treating dementia and a hyperactivity disorder, which includes a Galla rhois extract and fraxin as active ingredients. It was identified that the composition including the Galla rhois extract and fraxin significantly improves cognitive memory in an Alzheimer's disease model induced by Aβ (1-42) administration and an APPswe/PS1dE9 double-expressing Alzheimer's disease model, and inhibits the generation of amyloid plaques, suggesting the usefulness of the combination of the Galla rhois extract and fraxin, as a therapeutic material, against Alzheimer's disease, and showing that the combination of the Galla rhois extract and fraxin is able to be used as a therapeutic agent for ADHD.

The present invention relates to a composition for improving cognitive ability, and preventing or treating dementia and a hyperactivity disorder, which includes a Galla rhois extract and fraxin as active ingredients. It was identified that the composition including the Galla rhois extract and fraxin significantly improves cognitive memory in an Alzheimer's disease model induced by Aβ (1-42) administration and an APPswe/PS1dE9 double-expressing Alzheimer's disease model, and inhibits the generation of amyloid plaques, suggesting the usefulness of the combination of the Galla rhois extract and fraxin, as a therapeutic material, against Alzheimer's disease, and showing that the combination of the Galla rhois extract and fraxin is able to be used as a therapeutic agent for ADHD.

[Summary]

The present invention relates to an oral composition for animal, containing mastic resin and/or mastic essential oil as active components, especially a valid oral composition for pet animals, such as dogs and cats.

[Means for Solving the invention]

An oral composition for animal, for sterilizing a periodontal disease bacterium and an infection disease bacterium, characterized in that, said oral composition contains mastic resin as an active component, and said periodontal disease bacterium is Porphyromonas circumdentaria.

[Summary]

The present invention relates to an oral composition for animal, containing mastic resin and/or mastic essential oil as active components, especially a valid oral composition for pet animals, such as dogs and cats.

[Means for Solving the invention]

An oral composition for animal, for sterilizing a periodontal disease bacterium and an infection disease bacterium, characterized in that, said oral composition contains mastic resin as an active component, and said periodontal disease bacterium is Porphyromonas circumdentaria.

The invention relates to compositions and formulations comprising at least one triterpenoic acid and at least one neutral triterpenoid and uses thereof for treating optic neuropathy conditions.

The invention relates to compositions and formulations comprising at least one triterpenoic acid and at least one neutral triterpenoid and uses thereof for treating optic neuropathy conditions.

The invention relates to compositions and formulations comprising at least one triterpenoic acid and at least one neutral triterpenoid and uses thereof for treating optic neuropathy conditions.

A medicine developed for treatment of psoriasis and production method thereof are disclosed. This medicine for treatment of psoriasis developed in the scope of the present invention comprises tallow, larch resin, beeswax, gum mastic, propolis, Alkanna tinctoria, alum and Juniper tar. The production method of the psoriasis medicine of the present invention includes the steps of: Melting the tallow at 300° C. by continuously mixing it with the beeswax, adding first the gum mastica and then the propolis to the obtained molten mixture, adding ground larch resin to the mixture together with alum, finally adding ground Alkanna tinctoria and juniper tar to the mixture, obtaining a homogenous mixture by means of continuous mixing, filtering the homogenous mixture, obtaining the medicine for treatment of psoriasis, which is the final product in the form an elute.

A medicine developed for treatment of psoriasis and production method thereof are disclosed. This medicine for treatment of psoriasis developed in the scope of the present invention comprises tallow, larch resin, beeswax, gum mastic, propolis, Alkanna tinctoria, alum and Juniper tar. The production method of the psoriasis medicine of the present invention includes the steps of: Melting the tallow at 300° C. by continuously mixing it with the beeswax, adding first the gum mastica and then the propolis to the obtained molten mixture, adding ground larch resin to the mixture together with alum, finally adding ground Alkanna tinctoria and juniper tar to the mixture, obtaining a homogenous mixture by means of continuous mixing, filtering the homogenous mixture, obtaining the medicine for treatment of psoriasis, which is the final product in the form an elute.